Cargando…

Effects of Atypical Protein Kinase C Inhibitor (DNDA) on Lung Cancer Proliferation and Migration by PKC-ι/FAK Ubiquitination Through the Cbl-b Pathway

PURPOSE: The options for treating lung cancers are limited, as diagnosis typically occurs during the late stages of the disease. There is a dire need to develop aPKC (atypical Protein Kinase C) inhibitors due to aPKC overexpression and contributions to lung cancer malignancies. In this study, we inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	BommaReddy, Raja Reddy, Patel, Rekha, Smalley, Tracess, Acevedo-Duncan, Mildred
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047975/ https://www.ncbi.nlm.nih.gov/pubmed/32158232 http://dx.doi.org/10.2147/OTT.S224866

Ejemplares similares

The Atypical Protein Kinase C Small Molecule Inhibitor ζ-Stat, and Its Effects on Invasion Through Decreases in PKC-ζ Protein Expression
por: Smalley, Tracess, et al.
Publicado: (2020)

Simultaneous inhibition of atypical protein kinase-C and mTOR impedes bladder cancer cell progression
por: Patel, Rekha, et al.
Publicado: (2020)

Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis
por: Ratnayake, Wishrawana S., et al.
Publicado: (2017)

Oncogenic PKC-ι activates Vimentin during epithelial-mesenchymal transition in melanoma; a study based on PKC-ι and PKC-ζ specific inhibitors
por: Ratnayake, Wishrawana S., et al.
Publicado: (2018)

Inhibition of atypical protein kinase C-ι effectively reduces the malignancy of prostate cancer cells by downregulating the NF-κB signaling cascade
por: Apostolatos, André H., et al.
Publicado: (2018)

Analysis of PKC-ζ protein levels in normal and malignant breast tissue subtypes
por: Smalley, Tracess, et al.
Publicado: (2019)

The modulation of actin dynamics via atypical Protein Kinase-C activated Cofilin regulates metastasis of colorectal cancer cells
por: Islam, S M Anisul, et al.
Publicado: (2018)

Coordination of glioblastoma cell motility by PKCι
por: Baldwin, R Mitchell, et al.
Publicado: (2010)

Clinical significance of atypical protein kinase C (PKCι and PKCζ) and its relationship with yes-associated protein in lung adenocarcinoma
por: Kim, Kyung-Hee, et al.
Publicado: (2019)

PKCι and YAP1 are crucial in promoting pancreatic tumorigenesis
por: Wang, Peipei, et al.
Publicado: (2018)

Conditional knockout of polarity complex (atypical) PKCι reveals an anti-inflammatory function mediated by NF-κB
por: Forteza, Radia, et al.
Publicado: (2016)

PKCι depletion initiates mitotic slippage-induced senescence in glioblastoma
por: Restall, Ian J, et al.
Publicado: (2015)

Investigating pathogenic SNP of PKCι in HCV-induced hepatocellular carcinoma
por: Khan, Naila, et al.
Publicado: (2023)

Atypical protein kinase C iota (PKCλ/ι) ensures mammalian development by establishing the maternal–fetal exchange interface
por: Bhattacharya, Bhaswati, et al.
Publicado: (2020)

Control of atypical PKCι membrane dissociation by tyrosine phosphorylation within a PB1-C1 interdomain interface
por: Cobbaut, Mathias, et al.
Publicado: (2023)

PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis
por: Wang, Yin, et al.
Publicado: (2016)

c-CBL regulates melanoma proliferation, migration, invasion and the FAK-SRC-GRB2 nexus
por: Nihal, Minakshi, et al.
Publicado: (2016)

The aPKCι blocking agent ATM negatively regulates EMT and invasion of hepatocellular carcinoma
por: Ma, C Q, et al.
Publicado: (2014)

Lack of an association between the aPKCλ/ι expression in prostate cancer and the patient outcomes
por: Yokomizo, Yumiko, et al.
Publicado: (2017)

PKCλ/ι signaling—a common node for normal cellular development and breast oncogenesis
por: Paul, Arindam, et al.
Publicado: (2015)

Crystal Structure of the Cysteine Desulfurase DndA from Streptomyces lividans Which Is Involved in DNA Phosphorothioation
por: Chen, Fukun, et al.
Publicado: (2012)

Ubiquitin Ligases CBL and CBL-B Maintain the Homeostasis and Immune Quiescence of Dendritic Cells
por: Tong, Haijun, et al.
Publicado: (2021)

Ect2 links the PKCι-Par6α Complex to Rac1 Activation and Cellular Transformation
por: Justilien, Verline, et al.
Publicado: (2009)

PKCι interacts with Rab14 and modulates epithelial barrier function through regulation of claudin-2 levels
por: Lu, Ruifeng, et al.
Publicado: (2015)

The Rho family GEF FARP2 is activated by aPKCι to control tight junction formation and polarity
por: Elbediwy, Ahmed, et al.
Publicado: (2019)

Ubiquitin mediates the physical and functional interaction between human DNA polymerases η and ι
por: McIntyre, Justyna, et al.
Publicado: (2013)

aPKCι promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1
por: Tian, Li, et al.
Publicado: (2019)

Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma
por: Ito, Masaoki, et al.
Publicado: (2019)

Deficiency of PKCλ/ι alleviates the liver pathologic impairment of Schistosoma japonicum infection by thwarting Th2 response
por: Mei, Congjin, et al.
Publicado: (2022)

Loss of Cbl and Cbl-b ubiquitin ligases abrogates hematopoietic stem cell quiescence and sensitizes leukemic disease to chemotherapy
por: An, Wei, et al.
Publicado: (2015)

Downregulation of ASPP2 promotes gallbladder cancer metastasis and macrophage recruitment via aPKC-ι/GLI1 pathway
por: Tian, Li, et al.
Publicado: (2018)

The ΙgΕ-epitome viewed through the eyes of human monoclonal ΙgΕ
por: Levin, Mattias, et al.
Publicado: (2014)

Cbl ubiquitin ligases mediate the inhibition of natural killer cell activity
por: Matalon, Omri, et al.
Publicado: (2016)

Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency
por: Huemer, Martina, et al.
Publicado: (2016)

Atypical PKC: therapeutic target for Alzheimer’s?
por: Farese, Robert V., et al.
Publicado: (2018)

Enigma Prevents Cbl-c-Mediated Ubiquitination and Degradation of RETMEN2A
por: Kales, Stephen C., et al.
Publicado: (2014)

Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C-ι inhibitor as a potential prostate carcinoma therapeutic
por: Apostolatos, André H., et al.
Publicado: (2019)

Negative regulation of receptor tyrosine kinases by ubiquitination: Key roles of the Cbl family of E3 ubiquitin ligases
por: Tang, Rong, et al.
Publicado: (2022)

Transcription co-activator P300 activates Elk1-aPKC-ι signaling mediated epithelial-to-mesenchymal transition and malignancy in hepatocellular carcinoma
por: Ma, Chaoqun, et al.
Publicado: (2020)

Regulation of Lymphatic GM-CSF Expression by the E3 Ubiquitin Ligase Cbl-b
por: Peer, Sebastian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_910darnd67r4hvttj23sgnbjhf